© 2022 BioMarin. All rights reserved.

BioMarin to Participate in Three Upcoming Virtual Investor Conferences
- Morgan Stanley 19th Annual Global Healthcare Conference on September 10 at 1:15pm ET
- BofA Global Healthcare Conference 2021 on September 17 at 12:35pm ET/5:35pm BST
- J.P. Morgan 12th Annual U.S. All Stars Conference on September 22 at 12:00pm ET/5:00pm BST
Aug 25, 2021

SAN RAFAEL, Calif., Aug. 25, 2021 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming virtual investor conferences. An audio webcast of the presentations will be available live. You can access the webcasts at: https://investors.biomarin.com/. An archived version of the remarks will also be available through the Company's website for a limited time following the conference.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.




Traci McCarty

Debra Charlesworth

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.

(415) 455-7558 

(415) 455-7451


SOURCE BioMarin Pharmaceutical Inc.